CONTACT US
CORPORATE & U.S. HEADQUARTERS
New York
10 Hudson Yards
37th Floor
New York, NY 10001
RESEARCH & DEVELOPMENT HEADQUARTERS
San Diego
9520 Towne Centre Drive
Suite 200
San Diego, CA 92121
INTERNATIONAL HEADQUARTERS
London
Two Pancras Square
Kings Cross, London,
N1C 4AG, UK
Select a country below to see contact information specific to each country.
Medical information:
T: +43 1928 4012
E: medinfo@interceptpharma.com
To report adverse events:
T: +43 1928 4012
E: drugsafety@interceptpharma.com
Medical information:
T: +1 844-782-4278
E: medinfo@interceptpharma.com
To report adverse events:
T: +1 844-782-4278
E: drugsafety@interceptpharma.com
Medical information:
T: +353 144 75 196
E: medinfo@interceptpharma.com
To report adverse events:
T: +353 144 75 196
E: drugsafety@interceptpharma.com
Medical information:
T: +33 176 701 049
E: medinfo@interceptpharma.com
To report adverse events:
T: +33 130 087 281
E: pv-intercept@anticipsante.com
Or directly to the National Agency for the Safety of Medicines and Health Products at www.ansm.sante.fr
Medical information:
T: +49 30 30 80 767 5
E: medinfo@interceptpharma.com
To report adverse events:
T: +49 30 30 80 767 5
E: drugsafety@interceptpharma.com
Medical information:
T: +353 144 75 196
E: medinfo@interceptpharma.com
To report adverse events:
T: +353 144 75 196
E: drugsafety@interceptpharma.com
Medical information:
T: +353 144 75 196
E: medinfo@interceptpharma.com
To report adverse events:
T: +353 144 75 196
E: drugsafety@interceptpharma.com
Adverse events should be reported. Reporting forms and information can be found at www.hpra.ie
Medical information:
T: +39 0236026571
E: medinfo@interceptpharma.com
To report adverse events:
T: +39 050 9134
E: pv@regulatorypharmanet.com
Adverse events must be reported according to the procedures indicated by the Italian Medicines Agency at http://www.aifa.gov.it/content/come-segnalare-una-sospetta-reazione-avversa
Medical information:
T: (+352) 2786 1461
E: medinfo@interceptpharma.com
To report adverse events:
T: (+352) 2786 1461
E: drugsafety@interceptpharma.com
Adverse effects should be reported. The forms and information on this subject can be consulted on http://sante.public.lu/fr/prevention/medicaments-humains/surveillance-medicaments/index.html
To report an adverse event suspected to be drug related, please contact:
The Regional Pharmacovigilance Center of Lorraine
Or
The Pharmacy and Medicines Division of the Directorate of Health:
Medical information:
T: +353 144 75 196
E: medinfo@interceptpharma.com
To report adverse events:
T: +353 144 75 196
E: drugsafety@interceptpharma.com
Medical information:
T: +351 308 805 674
E: medinfo@interceptpharma.com
To report adverse events:
T: +351 308 805 674
E: drugsafety@interceptpharma.com
Adverse events should be reported. Information and forms for reporting an adverse event potentially related to an Intercept drug can be found at http://www.infarmed.pt/web/infarmed/submissaoram
Medical information:
T: +34 914 194 970
E: medinfo@interceptpharma.com
To report adverse events:
T: +34 914 194 970
E: drugsafety@interceptpharma.com
Adverse effects must be notified. The notification forms and information can be found at www.notificaRAM.es
Medical information:
T: +41 44 580 05 79
E: medinfo@interceptpharma.com
To report adverse events:
T: +41 44 580 05 79
E: drugsafety@interceptpharma.com
Medical information:
T: +44 330 100 3694
E: medinfo@interceptpharma.com
To report adverse events:
T: +44 330 100 3694
E: drugsafety@interceptpharma.com
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard
Medical information:
T: 1-844-782-4278
E: medinfo@interceptpharma.com
To report adverse events:
T: 1-844-782-4278
E: drugsafety@interceptpharma.com
You may also report directly to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch